Prosecution Insights
Last updated: April 19, 2026

Examiner: ALTER MORSCHAUSER, ALYSSA MARGO

Tech Center 3700 • Art Units: 3762 3792 3796

This examiner grants 77% of resolved cases

Performance Statistics

77.0%
Allow Rate
+7.0% vs TC avg
837
Total Applications
+15.8%
Interview Lift
1282
Avg Prosecution Days
Based on 786 resolved cases, 2023–2026

Rejection Statute Breakdown

4.5%
§101 Eligibility
32.2%
§102 Novelty
32.7%
§103 Obviousness
16.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17058313 AUTOMATIC SENSING OF FEATURES WITHIN AN ELECTROCARDIOGRAM Final Rejection Mayo Foundation for Medical Education and Research
18576237 PERSONALIZED THERAPY NEUROSTIMULATION SYSTEMS Non-Final OA Cala Health, Inc.
18600430 Seamlessly Embedded Heart Rate Monitor Non-Final OA Apple Inc.
18324228 NEUROMODULATION TO ENHANCE PHYSICAL ACTIVITY BEHAVIOR Final Rejection ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
19197410 SYSTEMS AND METHODS TO PLACE ONE OR MORE LEADS IN TISSUE TO ELECTRICALLY STIMULATE NERVES OF PASSAGE TO TREAT PAIN Final Rejection SPR THERAPEUTICS, INC.
18682972 METHOD AND SYSTEM FOR MONITORING PATIENTS FOR SEPSIS FOLLOWING DISCHARGE Non-Final OA KONINKLIJKE PHILIPS N.V.
18694140 MEDICAL DEVICE SYSTEM INCLUDING A PROGRAMMABLE IMPLANTABLE MEDICAL DEVICE SUCH AS A NEUROSTIMULATOR AND METHOD FOR OPERATING SAME Non-Final OA BIOTRONIK SE & Co. KG
18576467 Method for Fabricating a Medical Electrode Device Non-Final OA BIOTRONIK SE & Co. KG
18121899 Methods and Systems for Optimizing Placement of a Nerve Stimulation Device Final Rejection The Trustees of Columbia University in the City of New York
18175423 MACHINE LEARNING BASED HUMAN ACTIVITY RECOGNITION SYSTEM AND RELATED METHODS Non-Final OA UNIVERSITY OF SOUTH FLORIDA
18536633 APPARATUS, A SYSTEM AND A METHOD FOR STIMULATING A PART OF A PERIPHERAL NERVOUS SYSTEM Final Rejection Stichting IMEC Nederland
18265080 SURGICAL TOOL SUPPORT SYSTEM Final Rejection THE UAB RESEARCH FOUNDATION
18193923 Devices, Systems, And Methods For Applying Tumor-Treating Fields Non-Final OA NOVOCURE GMBH
18414173 IMPLANTABLE CLOSED-LOOP NEUROMODULATION DEVICE, SYSTEMS, AND METHODS OF USE Non-Final OA Iota Biosciences, Inc.
17789954 VAGUS NERVE STIMULATOR Final Rejection NEURIVE Co., Ltd.
18426616 INTELLIGENT DETERMINATION OF THERAPEUTIC STIMULATION INTENSITY FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION Non-Final OA Neurometrix, Inc.
18291439 RETAINING DEVICE FOR RETAINING A WEARABLE MONITORING DEVICE Non-Final OA UNEEG MEDICAL A/S
18576175 DEVICE FOR CARYING OUT DIATHERMIC AND MUSCLE STIMULATION TREATMENTS Non-Final OA Brera Medical Technologies S.R.L
18352846 SYSTEMS AND METHODS FOR DELIVERING NEUROSTIMULATION, INCLUDING REDUCED DOSES OF NEUROSTIMULATION Non-Final OA Nevro Corp.
18565094 ELECTROCARDIOGRAM ANALYSIS METHOD AND APPARATUS, ELECTRONIC DEVICE AND STORAGE MEDIUM Non-Final OA Hefei Heart Voice Health Technology Co., Ltd.
18148108 EVALUATING METHOD FOR USEFUL LIFESPAN OF CONDUCTIVE GEL AND NON-IMPLANTABLE ELECTRICAL STIMULATION DEVICE Non-Final OA GIMER MEDICAL. Co. LTD.
18277511 KIT FOR TREATING DAMAGED NERVES Non-Final OA Reddress Ltd.
18361611 WEARABLE NEUROSTIMULATOR WITH RIVET CONNECTION Final Rejection AVATION MEDICAL, INC.
18107241 SYSTEM, METHOD, AND APPARATUS FOR APPLYING BILATERAL TRANSCUTANEOUS ELECTRICAL STIMULATION Non-Final OA AVATION MEDICAL, INC.
18335121 WRIST-WORN NERVE STIMULATOR AND USE METHOD THEREFOR Final Rejection Fasikl Incorporated
18320806 SYSTEMS, DEVICES, AND METHODS FOR TRANSCUTANEOUS ELECTRICAL STIMULATION Final Rejection CEFALY Technology SPRL
17886358 EXTERNAL TRIGEMINAL NERVE STIMULATION FOR THE ACUTE NON-INVASIVE TREATMENT OF MIGRAINE ATTACKS Final Rejection CEFALY Technology SPRL

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month